Pfizer Goes Deeper Into Alzheimer’s Market With Medivation Deal
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the In Vivo blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Pfizer Finds Backup For Aricept In Medivation’s Dimebon
Medivation Alzheimer’s candidate is unique for its disease-modifying potential.
GSK Diversifies With Deal That Allows Bristol To Divest Non-Core Unit
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Lilly Adds To Oncology Pipeline With ImClone, Deciphera Deals
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.